Related Experiment Video

Updated: Jul 25, 2026

Induction and Assessment of Ischemia-reperfusion Injury in Langendorff-perfused Rat Hearts
07:58

Induction and Assessment of Ischemia-reperfusion Injury in Langendorff-perfused Rat Hearts

Published on: July 27, 2015

[The effect of thymogen on the heart in ischemia and reperfusion]

O V Filippova, K M Reznikov, V V Alabovskił

    Eksperimental'Naia I Klinicheskaia Farmakologiia
    |May 1, 1997
    PubMed

    Insights

    Thymogen demonstrates superior anti-ischemic and cardioprotective effects compared to dalargin and verapamil. Its protective mechanism does not involve opiate receptors or calcium channel blockade in cardiomyocytes.

    Area of Science:

    • Cardiovascular Pharmacology
    • Ischemic Heart Disease Research
    • Drug Discovery

    Background:

    • Ischemic heart disease remains a leading cause of mortality worldwide.
    • Developing effective cardioprotective agents is crucial for managing myocardial ischemia.
    • Current treatments have limitations, necessitating novel therapeutic strategies.

    Purpose of the Study:

    • To investigate the anti-ischemic properties of thymogen.
    • To compare the cardioprotective efficacy of thymogen against established drugs.
    • To elucidate the mechanism of thymogen's action.

    Main Methods:

    • Utilized an isolated heart model for experimental analysis.
    • Administered thymogen, dalargin, and verapamil to assess cardiac function.
    • Investigated the involvement of opiate receptors and calcium channels.

    Main Results:

    • Thymogen exhibited significant anti-ischemic effects.
    • The cardioprotective effect of thymogen surpassed that of dalargin and verapamil.
    • Thymogen's mechanism of action is independent of opiate receptors and calcium channel blockade.

    Conclusions:

    • Thymogen represents a promising therapeutic agent for myocardial ischemia.
    • Its unique mechanism offers a potential alternative to existing treatments.
    • Further research into thymogen's cardioprotective pathways is warranted.

    More Related Videos

    In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model08:22

    In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

    Published on: October 27, 2020

    Model of Ischemia and Reperfusion Injury in Rabbits06:11

    Model of Ischemia and Reperfusion Injury in Rabbits

    Published on: November 3, 2023

    Related Concept Videos

    Synthesis and Regulation of Thyroid Hormones01:20

    Synthesis and Regulation of Thyroid Hormones

    Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
    Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
    Functions of Thyroid Hormones01:18

    Functions of Thyroid Hormones

    The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
    TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
    Heart Failure Drugs: Inotropic Agents01:26

    Heart Failure Drugs: Inotropic Agents

    Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
    Ischemic Heart Disease: Overview01:17

    Ischemic Heart Disease: Overview

    Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
    Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
    Myocarditis I: Introduction01:21

    Myocarditis I: Introduction

    Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
    Hyperthyroidism II: Pathophysiology01:27

    Hyperthyroidism II: Pathophysiology

    Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...